Outcomes of Primary Percutaneous Intervention for ST-Segment Elevation Myocardial Infarction With Versus Without

Abhishek Chaturvedi1, Hector M Garcia-Garcia1, Matteo Cellamare2

  • 1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington DC.

Insights

Spontaneous coronary artery dissection (SCAD) patients with ST-elevation myocardial infarction (STEMI) experienced higher inpatient mortality and costs after primary percutaneous coronary interventions (PPCI) compared to non-SCAD patients. These concerning trends persist, highlighting the need for further research.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Spontaneous coronary artery dissection (SCAD) is a growing cause of acute coronary syndrome (ACS).
  • Optimal revascularization strategies for SCAD-related ST-elevation myocardial infarction (STEMI) remain unclear.
  • Prior international data suggested comparable outcomes between SCAD and non-SCAD patients undergoing primary percutaneous coronary intervention (PPCI).

Purpose of the Study:

  • To evaluate inpatient mortality and healthcare utilization for SCAD versus non-SCAD patients with STEMI undergoing PPCI in a contemporary US cohort.
  • To assess trends in outcomes for SCAD-STEMI patients over the past five years.

Main Methods:

  • Retrospective analysis of a contemporary US cohort.
  • Comparison of inpatient mortality, hospitalization duration, and costs between SCAD and non-SCAD patients with STEMI treated with PPCI.

Main Results:

  • SCAD patients exhibited higher inpatient mortality following PPCI for STEMI compared to non-SCAD patients.
  • The SCAD cohort experienced prolonged hospitalizations and increased hospitalization costs.
  • These disparities in outcomes have remained consistent over the last five years.

Conclusions:

  • SCAD patients with STEMI treated with PPCI face worse inpatient outcomes and higher costs than non-SCAD patients.
  • Findings challenge previous international data and underscore the need for cautious consideration of PPCI in SCAD-STEMI.
  • Further research, particularly prospective studies, is essential to clarify the role and optimal timing of PPCI in SCAD-STEMI management.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
919
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522